ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Henderson Chairs Reorganized NCA Centers Subcommittee; Core Grant Guidelines On Agenda

August 22, 1980

NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year

December 21, 1973

Surgical Oncologists Certification Asked By SSO Workshop

December 9, 1983

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005